JPWO2020219646A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020219646A5 JPWO2020219646A5 JP2021563196A JP2021563196A JPWO2020219646A5 JP WO2020219646 A5 JPWO2020219646 A5 JP WO2020219646A5 JP 2021563196 A JP2021563196 A JP 2021563196A JP 2021563196 A JP2021563196 A JP 2021563196A JP WO2020219646 A5 JPWO2020219646 A5 JP WO2020219646A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- composition
- subject
- tau
- administering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837987P | 2019-04-24 | 2019-04-24 | |
| US62/837,987 | 2019-04-24 | ||
| PCT/US2020/029477 WO2020219646A1 (en) | 2019-04-24 | 2020-04-23 | Heterologous administration of tau vaccines |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022529529A JP2022529529A (ja) | 2022-06-22 |
| JP2022529529A5 JP2022529529A5 (https=) | 2023-09-04 |
| JPWO2020219646A5 true JPWO2020219646A5 (https=) | 2023-09-04 |
| JP7617852B2 JP7617852B2 (ja) | 2025-01-20 |
Family
ID=72921263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563196A Active JP7617852B2 (ja) | 2019-04-24 | 2020-04-23 | タウワクチンの異種投与 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US11591377B2 (https=) |
| EP (1) | EP3965817A4 (https=) |
| JP (1) | JP7617852B2 (https=) |
| KR (1) | KR20220005033A (https=) |
| CN (1) | CN114173812A (https=) |
| AU (1) | AU2020262899A1 (https=) |
| BR (1) | BR112021021213A2 (https=) |
| CA (1) | CA3137884A1 (https=) |
| EA (1) | EA202192891A1 (https=) |
| IL (1) | IL287486A (https=) |
| JO (1) | JOP20210284A1 (https=) |
| MA (1) | MA55902A (https=) |
| MX (1) | MX2021012994A (https=) |
| PH (1) | PH12021552683A1 (https=) |
| SG (1) | SG11202111770RA (https=) |
| TW (1) | TW202110478A (https=) |
| WO (1) | WO2020219646A1 (https=) |
| ZA (1) | ZA202108168B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018308088B2 (en) | 2017-07-25 | 2025-05-29 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| KR102710762B1 (ko) | 2017-10-25 | 2024-09-25 | 얀센 파마슈티칼즈, 인코포레이티드 | 인산화 타우 펩티드의 조성물 및 이의 용도 |
| AU2020214796A1 (en) | 2019-01-30 | 2021-07-29 | Truebinding, Inc. | Anti-Gal3 antibodies and uses thereof |
| AU2020219804A1 (en) | 2019-02-08 | 2021-08-19 | Ac Immune S.A. | Method of safe administration of phosphorylated Tau peptide vaccine |
| KR20230037502A (ko) * | 2020-05-20 | 2023-03-16 | 바이사이클티엑스 리미티드 | 넥틴-4에 특이적인 바이사이클릭 펩티드 리간드 및 이의 용도 |
| WO2021242776A2 (en) | 2020-05-26 | 2021-12-02 | Truebinding, Inc. | Methods of treating inflammatory diseases by blocking galectin-3 |
| JP2024532787A (ja) * | 2021-08-12 | 2024-09-10 | ヤンセン ファーマシューティカルズ，インコーポレーテッド | 持続的な免疫応答を誘導するためのリン酸化タウペプチドを含むリポソーム |
| WO2023056369A1 (en) * | 2021-09-29 | 2023-04-06 | Janssen Pharmaceuticals, Inc. | Method of safe administration of tau phosphopeptide conjugate |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811310A (en) | 1986-09-30 | 1998-09-22 | Albert Einstein College Of Medicine Of Yeshiva Univ. | The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease |
| HU212924B (en) | 1989-05-25 | 1996-12-30 | Chiron Corp | Adjuvant formulation comprising a submicron oil droplet emulsion |
| US7408027B1 (en) | 1991-12-06 | 2008-08-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenchaften | Tools for the diagnosis and treatment of Alzheimer's disease |
| DE69318420T2 (de) | 1992-12-14 | 1999-01-28 | Naamloze Vennootschap Innogenetics S.A., Gent | Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung |
| US7427392B1 (en) | 1994-11-14 | 2008-09-23 | Elan Pharmaceuticals, Inc. | Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau |
| US20020086009A1 (en) | 1996-03-13 | 2002-07-04 | Koichi Ishiguro | Anti-phosphorylated tau protein antibodies and methods for detecting alzheimer`s disease with the use of the same |
| WO1998022120A1 (en) | 1996-11-19 | 1998-05-28 | The Wistar Institute Of Anatomy & Biology | Diagnostic and therapeutic reagents for alzheimer's disease |
| CA2415919A1 (en) | 2000-07-11 | 2002-01-17 | Molecular Geriatrics Corporation | Reagents and methods for identification of binding agents |
| EP1474432A1 (en) | 2002-02-04 | 2004-11-10 | Biomira Inc. | Immunostimulatory, covalently lipidated oligonucleotides |
| JP4662719B2 (ja) | 2002-04-19 | 2011-03-30 | ザ ガバニング カウンシル オブ ザ ユニバーシティ オブ トロント | アルツハイマー病の処置のための免疫学的方法および組成物 |
| US8663650B2 (en) | 2003-02-21 | 2014-03-04 | Ac Immune Sa | Methods and compositions comprising supramolecular constructs |
| US20050261475A1 (en) | 2004-02-13 | 2005-11-24 | Harvard Medical School | Solid-phase capture-release-tag methods for phosphoproteomic analyses |
| US7238788B2 (en) | 2004-02-18 | 2007-07-03 | University Of Iowa Foundation | Antibodies to phosphorylated tau, methods of making and methods of use |
| CA2633399C (en) | 2005-12-12 | 2016-01-26 | Ac Immune S.A. | Therapeutic vaccine |
| WO2007068105A1 (en) | 2005-12-12 | 2007-06-21 | Robarts Research Institute | Method of diagnosing amyotrophic lateral sclerosis |
| US8012936B2 (en) | 2006-03-29 | 2011-09-06 | New York University | Tau fragments for immunotherapy |
| WO2008140639A2 (en) | 2007-02-08 | 2008-11-20 | Oligomerix, Inc. | Biomarkers and assays for alzheimer's disease |
| JPWO2009051220A1 (ja) | 2007-10-19 | 2011-03-03 | イムナス・ファーマ株式会社 | Ａβオリゴマーに特異的に結合する抗体およびその利用 |
| SI2408807T1 (sl) * | 2009-03-18 | 2021-11-30 | Ac Immune Sa | Postopek za terapevtsko uporabo |
| UA107571C2 (xx) | 2009-04-03 | 2015-01-26 | Фармацевтична композиція | |
| CA3239368A1 (en) | 2009-06-10 | 2010-12-16 | New York University | Immunological targeting of pathological tau proteins |
| NZ598356A (en) | 2009-07-30 | 2014-06-27 | Pfizer Vaccines Llc | Antigenic tau peptides and uses thereof |
| EP3527220A1 (en) | 2010-08-12 | 2019-08-21 | AC Immune S.A. | Vaccine engineering |
| AR083561A1 (es) * | 2010-10-26 | 2013-03-06 | Ac Immune Sa | Preparacion de una construccion antigenica |
| ES2656442T3 (es) * | 2011-09-19 | 2018-02-27 | Axon Neuroscience Se | Terapia basada en proteínas y diagnóstico de una patología mediada por tau en la enfermedad de Alzheimer |
| WO2015122922A1 (en) * | 2014-02-14 | 2015-08-20 | Ipierian, Inc. | Tau peptides, anti-tau antibodies, and methods of use thereof |
| WO2015197820A1 (en) | 2014-06-26 | 2015-12-30 | Crucell Holland B.V. | Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau |
| EP4465050A3 (en) * | 2015-06-05 | 2025-06-11 | Genentech, Inc. | Anti-tau antibodies and methods of use |
| MA48595A (fr) | 2016-12-07 | 2020-03-18 | Ac Immune Sa | Anticorps anti-tau et leurs méthodes d'utilisation |
| KR102710762B1 (ko) | 2017-10-25 | 2024-09-25 | 얀센 파마슈티칼즈, 인코포레이티드 | 인산화 타우 펩티드의 조성물 및 이의 용도 |
| EP3706795A4 (en) | 2017-11-09 | 2021-10-13 | Pinteon Therapeutics Inc. | METHODS AND COMPOSITIONS FOR GENERATING AND USING HUMANIZED CONFORMATION SPECIFIC PHOSPHORYLATED TAU ANTIBODIES |
-
2020
- 2020-04-23 EA EA202192891A patent/EA202192891A1/ru unknown
- 2020-04-23 CN CN202080046201.9A patent/CN114173812A/zh active Pending
- 2020-04-23 CA CA3137884A patent/CA3137884A1/en active Pending
- 2020-04-23 EP EP20796144.2A patent/EP3965817A4/en active Pending
- 2020-04-23 MA MA055902A patent/MA55902A/fr unknown
- 2020-04-23 BR BR112021021213A patent/BR112021021213A2/pt unknown
- 2020-04-23 PH PH1/2021/552683A patent/PH12021552683A1/en unknown
- 2020-04-23 MX MX2021012994A patent/MX2021012994A/es unknown
- 2020-04-23 AU AU2020262899A patent/AU2020262899A1/en not_active Abandoned
- 2020-04-23 TW TW109113654A patent/TW202110478A/zh unknown
- 2020-04-23 SG SG11202111770RA patent/SG11202111770RA/en unknown
- 2020-04-23 US US16/856,400 patent/US11591377B2/en active Active
- 2020-04-23 KR KR1020217038109A patent/KR20220005033A/ko active Pending
- 2020-04-23 WO PCT/US2020/029477 patent/WO2020219646A1/en not_active Ceased
- 2020-04-23 JP JP2021563196A patent/JP7617852B2/ja active Active
- 2020-04-23 JO JOP/2021/0284A patent/JOP20210284A1/ar unknown
-
2021
- 2021-10-21 IL IL287486A patent/IL287486A/en unknown
- 2021-10-22 ZA ZA2021/08168A patent/ZA202108168B/en unknown
-
2023
- 2023-02-20 US US18/171,498 patent/US20230257433A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250326806A1 (en) | Compositions of Phosphorylated Tau Peptides and Uses Thereof | |
| JP7617852B2 (ja) | タウワクチンの異種投与 | |
| JPWO2020219646A5 (https=) | ||
| JPWO2019084118A5 (https=) | ||
| US20250152684A1 (en) | Anti-Alpha-Synuclein Therapeutic Vaccines | |
| JPWO2020163730A5 (https=) | ||
| CN118660717A (zh) | 抗α-突触核蛋白的治疗性疫苗 | |
| JP2026505011A (ja) | リポソーム構築物 | |
| US20250144212A1 (en) | Liposomes containing phosphorylated tau peptides for inducing sustained immune responses | |
| HK40105209A (zh) | 磷酸化tau肽的组合物及其用途 | |
| RU2025121137A (ru) | Терапия на основе вакцины против бета-амилоида | |
| EA051687B1 (ru) | Терапевтические вакцины против альфа-синуклеина | |
| HK40039870B (zh) | 磷酸化Tau肽的组合物及其用途 | |
| HK40039870A (en) | Compositions of phosphorylated tau peptides and uses thereof | |
| EA044254B1 (ru) | Композиции фосфорилированных тау-пептидов и их применения |